Fig. 2.
Fig. 2. Percentages of CD38+/CD5+/CD19+ cells among mutated and unmutated B-CLL cases. The percentages of CD38-expressing B-CLL cells among patients (n = 37) whose Ig VH and VL genes had been sequenced. Unmutated cases (⧫) display <2.0% differences from the most similar germline gene; mutated samples (⋄) display ≥2% differences. Note that all of the cases (17 of 17) that have ≥30% CD38+ B-CLL cells were unmutated, whereas only 3 unmutated cases expressed low numbers (<30%) of CD38+ B-CLL cells. These comparisons are statistically significant (P = .00001; Mann-Whitney test).

Percentages of CD38+/CD5+/CD19+ cells among mutated and unmutated B-CLL cases. The percentages of CD38-expressing B-CLL cells among patients (n = 37) whose Ig VH and VL genes had been sequenced. Unmutated cases (⧫) display <2.0% differences from the most similar germline gene; mutated samples (⋄) display ≥2% differences. Note that all of the cases (17 of 17) that have ≥30% CD38+ B-CLL cells were unmutated, whereas only 3 unmutated cases expressed low numbers (<30%) of CD38+ B-CLL cells. These comparisons are statistically significant (P = .00001; Mann-Whitney test).

Close Modal

or Create an Account

Close Modal
Close Modal